News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DURECT (DRRX) Announces Second Quarter 2017 Financial Results And Provides Corporate Update



8/9/2017 12:24:44 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
CUPERTINO, Calif., Aug. 8, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2017 and provided a corporate update.

Executed a U.S. commercialization agreement with Sandoz for POSIMIRĀ®, including a $20 million upfront payment, as well as milestone payments and double digit royalties.

Total revenues were $4.3 million and net loss was $9.9 million for the three months ended June 30, 2017 as compared to total revenues of $3.2 million and net loss of $9.0 million for the three months ended June 30, 2016.

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES